Rare diseases
Showing of 5 results
The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programs to Develop New Therapies for Friedreich’s Ataxia
Philanthropic donation of up to £650,000 (approx. $823,000 USD) will enable the launch of two new grant award programs to support the research and development of greatly needed therapeutics for Friedreich’s Ataxia (FA).
Oxford-Harrington Rare Disease Centre to Hold Webinar Entitled Pioneering a Path to Rare Disease Therapeutics
OHC’s 4th Rare Disease Day webinar to be held on Feb. 28, 2024 at 10 a.m. ET 3 p.m. GMT.
Oxford-Harrington Rare Disease Centre Opens Call for Proposals
New Scholar Award Accelerates Novel Therapies for Rare Diseases.
Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial
Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.
Oxford-Harrington Rare Disease Centre to Advance Novel Treatment for Duchenne Muscular Dystrophy
New therapy seeks to protect from rare muscle-wasting disorder.
Results are loading...